• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION 3F AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION 3F AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 1000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Stroke/CVA (1770); Myocardial Infarction (1969); Blood Loss (2597)
Event Date 10/17/2015
Event Type  Injury  
Manufacturer Narrative
Citation: r.Sorabella et al."aortic root replacement in octogenarians offers acceptable perioperative and late outcomes".Ann thorac surg 2016;101:967¿73.Http://dx.Doi.Org/10.1016/j.Athoracsur.2015.08.006 earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding aortic root replacement in octogenarians offers acceptable perioperative and late outcomes.All data were collected from a single center between 2005 and 2012.The study population included 592 patients (predominantly male, mean age 58 years for the less than 80 group and mean age of 83 for the over 80 group), 214 of which were implanted with medtronic 3f (serial numbers not provided).Among all patients 15 deaths occurred.Based on the available information, none of the deaths were attributed to medtronic product.Among all patients adverse events included: bleeding, stroke, new need for renal therapy, myocardial infarction, atrial fibrillation, new pacemaker placement, reoperations.Based on the available information, these adverse events may have been attributed to medtronic product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3F AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6853384
MDR Text Key85456953
Report Number2025587-2017-01562
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
Report Date 08/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1000
Device Catalogue Number1000
Was Device Available for Evaluation? No
Date Manufacturer Received08/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-